Clinical Evaluation of an Investigational Blood Creatinine Point-of-Care Test Device
Observational
Observational Model: Cohort, Time Perspective: Prospective
The primary outcomes would be, reduced wait time and increased patient satisfaction.
conclusion of the study
No
Martin Fleisher, PhD
Principal Investigator
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
07-023
NCT00607529
August 2007
May 2010
Name | Location |
---|---|
Memorial Sloan Kettering Cancer Center | New York, New York 10021 |